Petros Pharmaceuticals, Inc. Public Float
Petros Pharmaceuticals, Inc. (PTPI) had Public Float of $1.44 million as of 2025-06-30, per its 10-K filed 2026-04-15.
Financial Statements › Notes › Cover Page
dei:EntityPublicFloat · last filed 2026-04-15
- 2025-06-30: Entity Public Float $1.44M.
- 2024-06-30: Entity Public Float $3.95M.
- 2023-06-30: Entity Public Float $3.15M.
- 2022-06-30: Entity Public Float $12.57M.
| Period end | Entity Public Float |
|---|---|
| 2025-06-30 | $1.44M 10-K · filed 2026-04-15 |
| 2024-06-30 | $3.95M 10-K · filed 2025-03-31 |
| 2023-06-30 | $3.15M 10-K/A · filed 2024-05-31 |
| 2022-06-30 | $12.57M 10-K · filed 2023-03-31 |
| 2021-06-30 | $20.06M 10-K · filed 2022-03-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Alaunos Therapeutics, Inc. (TCRT) | United States | $0.003B | -1.44 |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| Sunshine Biopharma Inc. (SBFM) | $0.003B |